Merck

Loading...

Impact of Synthia on GSK Chemical Development

On-demand webinars
Englisch
53 min

The webinar focused on the advancements in SYNTHIA™ Retrosynthesis Software and its impact on chemical development at GlaxoSmithKline (GSK), presented by John Lim from GSK. John highlighted how SYNTHIA™ has become an integral tool in GSK's chemical development process, aiding in route selection and synthesis planning. The software's ability to suggest diverse, high-quality synthetic routes has enhanced GSK's confidence in their chosen pathways...

John Lim

Senior Scientist API Chemistry, GSK Chemical Development

Dr. Ewa Gajewska

Head of Product Management

Register for webinar

John  Lim Dr. Ewa  Gajewska

John Lim, Dr. Ewa Gajewska

Impact of Synthia on GSK Chemical Development

On-demand webinars
Englisch
53 min
Merck Life Science KGaA
All about Merck

Topics